Home  >  Products  >  ITGAV (integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) ) Blocking Peptide (the C terminal of ITGAV)(100ug)
ITGAV (integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) ) Blocking Peptide (the C terminal of ITGAV)(100ug)

ITGAV (integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) ) Blocking Peptide (the C terminal of ITGAV)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ITGAV Antibody (ARP64575_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP64575
Size: 100ug
Weight: 100kDa
Gene: 3685
Format: Lyophilized powder
Target: ITAGV encodes integrin alpha chain V. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. The I-domain containing integrin alpha V undergoes post-translational cleavage to yield disulfide-linked heavy and light chains, that combine with multiple integrin beta chains to form different integrins. Among the known associating beta chains (beta chains 1,3,5,6, and 8; 'ITGB1', 'ITGB3', 'ITGB5', 'ITGB6', and 'ITGB8'), each can interact with extracellular matrix ligands; the alpha V beta 3 integrin, perhaps the most studied of these, is referred to as the Vitronectin receptor (VNR). In addition to adhesion, many integrins are known to facilitate signal transduction. Alternative splicing results in multiple transcript variants.
Alternative names: CD51; DKFZp686A08142; MSK8; VNRA
See Full Product Listings >